
|Articles|November 1, 2003
HAART's Impact on Care
Las Vegas -- The landscape of dermatologic diseases manifested by HIV-positive (HIV+) patients has changed in the era of highly active antiretroviral therapy (HAART), said Clay J. Cockerell, M.D., at the Fall Clinical Dermatology Conference.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Addressing Delays in Prior Authorization Processes That Negatively Impact Patients
2
Meta-analysis Confirms Benefits of Roflumilast 0.3% Cream for PsO
3
Transformative Advances This Year and Beyond
4
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
5


















